Starting August 16, RudaCure CEO Yongho Kim will attend UKC2022 (US Korea Conference, Hyatt Regency Crystal City, Arlington, VA).
This attendance is for the Startup Pitch Competition scheduled for August 20, where companies that passed the Semi-Final round have the opportunity to present their final IR pitches.
RudaCure was recognized for the technical capability and market potential of its pipelines including RCI001 and RCI002, earning a spot in the final round IR opportunity. Starting with UKC2022, the company will engage in full-scale U.S. investment attraction activities, including attending the RESI (Redefining Early Stage Investments) Conference in September.
The SPC (Startup Pitch Competition) is scheduled to take place on August 20 (U.S. time) from 08:30–10:30 AM, with participation from U.S.-based VCs and Korean-American scientists.
UKC2022 is jointly organized by the Korean-American Scientists and Engineers Association (KSEA) and the Korean Federation of Science and Technology Societies (KOFST), and is known to bring together presidents of various Korean universities at once.
RESI will be held in Boston from September 21 to 23. The IR presentations will feature companies selected through the Shinhan Square Bridge Competition for oral presentations. RudaCure once again earned the opportunity to participate in the final round with high expectations and a strong track record.
